By adopting a fresh approach that places the right people in the right programs, including AI-enabled enrollment, health plans, the healthcare industry will be in a better position to weather impending federal cuts – and maybe even end up better for it. The post How the Healthcare Industry Can Soften Blow from Medicaid Cuts appeared…
Customers are no longer willing to accept vague assurances about security. Instead, they expect evidence of secure design, documented vulnerability management processes, and transparency about software components. The post Healthcare’s Security Awakening Testing Patience of Medical Device Buyers appeared first on MedCity News.
DENVER — Outside HCA HealthONE Rose medical center, the snow is flying. Inside, on the third floor, there’s a flurry of activity within the labor and delivery unit. “There’s a lot of action up here. It can be very stressful at times,” said Kristina Fraser, an OB-GYN in blue scrubs. Nurses wheel a very pregnant…
By KIM BELLARD The article I can’t get out of my head is one by Greg Ip in The Wall Street Journal: Crises at Boeing and Intel Area National Emergency. I’m old enough that I remember when the Boeing 707 took airline passenger travel from the prop age to the jet age. I’m old enough…
A planned interim clinical trial analysis found Praxis Precision Medicines drug ulixacaltamide was unlikely to succeed as a treatment for essential tremor. But Praxis is continuing two late-stage tests of the drug; data are expected in the third quarter of 2025. The post Praxis Presses Forward in Essential Tremor Despite Futility Finding From Trial Observers…
Experts warn that the Trump administration’s new $100,000 fee for H-1B visa applications could worsen healthcare’s workforce crisis, especially in rural areas, by making it prohibitively expensive for hospitals to hire international clinicians. Critics are also worried that the change could slow the pace of healthcare innovation by discouraging foreign workers from contributing to the…
Discover the cutting-edge AI software that empowers trauma and critical care teams with real-time, data-driven insights. The post TraumaCare.AI shaping the future of critical care with AI-powered innovation appeared first on MedCity News.
Más de una docena de clínicas de vacunación se cancelaron en el condado de Pima, en Arizona. También una campaña en medios para que los niños de bajos recursos del condado de Washoe, en Nevada, se pusieran al día con sus vacunas. Otras clínicas planificadas se cancelaran en Texas, Minnesota y Washington, entre otros lugares….
That is what an analysis from PwC finds, at least with respect to stock market returns. Our PwC equal-weight index of 50 pharma companies analyzes the sector’s total shareholder returns performance relative to the S&P 500 Equal Weighted Index. From 2018 through November 2024, the PwC pharma index returned 7.6% to shareholders, compared with more…
Romvimza, a drug for treating tenosynovial giant cell tumor, was initially developed by Deciphera Pharmaceuticals. Last year, Ono Pharmaceutical acquired Deciphera to build up its oncology portfolio and expand its business prospects in the U.S. and Europe. The post Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor…